Suchergebnisse - "Taramasso, Lucia"

PubPharm (10)

1

Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors : A retrospective cohort study

enthalten in: Journal of medical virology | 2023

von Lagi, F. | Giacomelli, A. | Borghi, V. | +12

2

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen : Data from a Real-Life Setting

enthalten in: Viruses | 2023

von Maggi, P. | Ricci, E. | Martinelli, C. | +27

3

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens

enthalten in: BMC infectious diseases | 2023

von Maggi, P. | Ricci, E. | Cicalini, S. | +18

4

Causes of HIV Treatment Interruption during the Last 20 Years : A Multi-Cohort Real-Life Study

enthalten in: Viruses | 2023

von De Vito, A. | Ricci, E. | Menzaghi, B. | +18

5

Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV

enthalten in: AIDS research and human retroviruses | 2022

von Taramasso, L. | Lo Caputo, S. | Magnasco, L. | +12

6

The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen

enthalten in: AIDS (London, England) | 2020

von Taramasso, L. | Berruti, M. | Briano, F. | +1

7

Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine : Different effects in patients with or without baseline hypercholesterolemia

enthalten in: PloS one | 2019

von Taramasso, L. | Di Biagio, A. | Riccardi, N. | +7

8

Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients

enthalten in: Journal of the International Association of Providers of AIDS Care | 2019

von Riccardi, N. | Del Puente, F. | Taramasso, L. | +1

9

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors : results from a large observational cohort study (SCOLTA)

enthalten in: BMC infectious diseases | 2018

von Taramasso, L. | Tatarelli, P. | Ricci, E. | +56

10

Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides

enthalten in: International journal of antimicrobial agents | 2016

von Di Biagio, A. | Riccardi, N. | Taramasso, L. | +9

1
[1]